NAV — Navco Pharmaceuticals Balance Sheet
0.000.00%
Last trade - 00:00- CA$1.43m
- CA$1.51m
Annual balance sheet for Navco Pharmaceuticals, fiscal year end - September 30th, CAD millions except per share, conversion factor applied.
2022 June 30th | 2023 September 30th | |
|---|---|---|
| Period Length: | — | — |
| Source: | ARS | ARS |
| Standards: | IFRS | IFRS |
| Status: | Final | Final |
| Cash | ||
| Cash and Short Term Investments | 0.002 | 0.235 |
| Net Total Accounts Receivable | ||
| Net Total Receivables | 0.11 | 0.046 |
| Total Inventory | ||
| Prepaid Expenses | ||
| Total Current Assets | 0.112 | 0.711 |
| Gross Property, Plant And Equipment | ||
| Accumulated Depreciation | ||
| Net Property, Plant And Equipment | — | 0.184 |
| Net Intangible Assets | ||
| Total Assets | 0.112 | 0.932 |
| Accounts Payable | ||
| Accrued Expenses | ||
| Notes Payable / Short Term Debt | ||
| Current Portion of Long Term Debt / Capital Leases | ||
| Total Other Current Liabilities | ||
| Total Current Liabilities | 0.109 | 0.753 |
| Capital Lease Obligations | ||
| Total Long Term Debt | ||
| Total Debt | ||
| Total Liabilities | 0.109 | 0.844 |
| Common Stock | ||
| Retained Earnings (Accumulated Deficit) | ||
| Total Equity | 0.003 | 0.087 |
| Total Liabilities & Shareholders' Equity | 0.112 | 0.932 |
| Total Common Shares Outstanding |